Table 1.

Comparison of tamoxifen with the control and placebo

Items	Fibrotic tissue (thickness, mm)	Angiogenesis (vessels/HPF)	Scar surface area (mm2)
Tamoxifen	1.00 (0.95, 1.02)	8.00 (6.75, 9.25)	77.50 (52.00, 100.00)
Control	1.35 (1.15, 1.62)	3.50 (3.00, 6.25)	89.00 (69.00, 112.50)
Placebo	1.25 (0.80, 1.50)	7.00 (5.50, 8.25)	49.00 (39.00, 60.00)
P-value	0.069	0.067	0.028
Pairwise comparisons by the Dunn method
A versus B	--a)	--a)	0.990
A versus C	--a)	--a)	0.160
B versus C	--a)	--a)	0.032

Data are presented as median (IQR=[Q1, Q3]).

HPF, high-power field; A, tamoxifen; B, control; C, placebo.

^a)Multiple comparisons were not performed because the Kruskal-Wallis test results were not significantly different.